Concepedia

R. Marwood

RM

Statistics

Publications

7

Citations

526

H-Index

7

Active since

1992

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

MSD (UK) Limited (United Kingdom)

R. Marwood is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, pharmacology, and neuropharmacology.

Top concepts

Publications per year

1992–1999

7

Publications

7

Expression and pharmacological characterization of the human D3 dopamine receptor.

Stephen B. Freedman, Shil Patel, R. Marwood et al. · Journal of Pharmacology and Experimental Therapeutics · 1994 · 224 citations · Full text

Antinociceptive and toxic effects of (+)‐epibatidine oxalate attributable to nicotinic agonist activity

N.M.J. Rupniak, Sushma Patel, R. Marwood et al. · British Journal of Pharmacology · 1994 · 55 citations · Full text

, , +20

Stable expression of human D<sub>3</sub> dopamine receptors in GH<sub>4</sub>C<sub>1</sub> pituitary cells

Guy R. Seabrook, Smita S. Patel, R. Marwood et al. · FEBS Letters · 1992 · 55 citations · Full text

, , +21

1-(3-Cyanobenzylpiperidin-4-yl)-5-methyl-4-phenyl-1,3-dihydroimidazol-2-one:  A Selective High-Affinity Antagonist for the Human Dopamine D<sub>4</sub>Receptor with Excellent Selectivity over Ion Channels

Robert W. Carling, Kevin W. Moore, Christopher R. Moyes et al. · Journal of Medicinal Chemistry · 1999 · 53 citations · Full text

, , +22

Identification and pharmacological characterization of [125I]L-750,667, a novel radioligand for the dopamine D4 receptor.

Shil Patel, Shil Patel, R. Marwood et al. · Molecular Pharmacology · 1996 · 49 citations

1–5 of 7